Tower Research Capital LLC (TRC) - ONCOLYTICS BIOTECH INC ownership

ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 42 filers reported holding ONCOLYTICS BIOTECH INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ONCOLYTICS BIOTECH INC
ValueSharesWeighting
Q2 2023$6,861
+36010.5%
2,639
-83.5%
0.00%
-100.0%
Q1 2023$19
+111.1%
16,017
+185.3%
0.00%
Q4 2022$9
-99.8%
5,615
+47.3%
0.00%
Q3 2022$5,000
-16.7%
3,813
-38.7%
0.00%
Q2 2022$6,000
+200.0%
6,222
+557.0%
0.00%
Q1 2022$2,000
-33.3%
947
-44.7%
0.00%
Q4 2021$3,000
-50.0%
1,714
-20.6%
0.00%
Q2 2021$6,0002,160
+3500.0%
0.00%
Q3 2020$0600.00%
Other shareholders
ONCOLYTICS BIOTECH INC shareholders Q2 2022
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 25,000$410.05%
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 183,783$299,5660.03%
BRAVE ASSET MANAGEMENT INC 20,000$32,7720.01%
Newman Dignan & Sheerar, Inc. 18,915$30,8310.01%
Virtu Financial LLC 24,953$410.01%
Long Focus Capital Management, LLC 40,000$65,2000.00%
Cedar Mountain Advisors, LLC 5,651$9,2110.00%
Banque Cantonale Vaudoise 11,900$190.00%
SITTNER & NELSON, LLC 1,000$1,6390.00%
OSAIC HOLDINGS, INC. 8,332$13,0000.00%
View complete list of ONCOLYTICS BIOTECH INC shareholders